EADIE TECHNOLOGIES Transforming Visual Field Testing OPPORTUNITY Eadie

  • Slides: 22
Download presentation
EADIE TECHNOLOGIES Transforming Visual Field Testing

EADIE TECHNOLOGIES Transforming Visual Field Testing

OPPORTUNITY Eadie. Tech is replacing the existing desktop diagnostic hardware with a custom system

OPPORTUNITY Eadie. Tech is replacing the existing desktop diagnostic hardware with a custom system including a head-mounted device, software, novel algorithms, and a cloud-based infrastructure – higher margins, more comfortable tests, more accurate diagnostics, greater accessibility Prototype completed and market need validated Raising $500 K to finalize software and hardware MVP by September 2020

NEED • More than 12 million people in the US have glaucoma • Most

NEED • More than 12 million people in the US have glaucoma • Most patients are not able to obtain frequent enough testing • 50% of glaucoma is undiagnosed due to poor access to testing • Personal and economic impact of blindness and low-vision can be prevented, at a much lower cost, if detected early

CURRENT ‘BEST’ PRACTICE • Patients sit at a machine and clicks a button •

CURRENT ‘BEST’ PRACTICE • Patients sit at a machine and clicks a button • Limited throughput – one patient and one eye at a time • Results are often unreliable

EADIETECH HAS DEVELOPED A SYSTEM WITH MULTIPLE, CUSTOM HEAD MOUNTED DEVICES For superior visual

EADIETECH HAS DEVELOPED A SYSTEM WITH MULTIPLE, CUSTOM HEAD MOUNTED DEVICES For superior visual field testing than the current gold standard!

Advantage #1 • Improved accuracy and reliability Advantage #2 • Improved accessibility • Improved

Advantage #1 • Improved accuracy and reliability Advantage #2 • Improved accessibility • Improved throughput • Reduced overhead costs

Advantage #3 • Improved patient comfort Advantage #4 • Leverage cloud AI deployment to

Advantage #3 • Improved patient comfort Advantage #4 • Leverage cloud AI deployment to continually improve diagnostic and predictive capacity

INTELLECTUAL PROPERTY Comprehensive provisional patent submission imminent

INTELLECTUAL PROPERTY Comprehensive provisional patent submission imminent

IMPACT Clinicians – increase testing capacity 2 -4 fold = increased revenue Patients –

IMPACT Clinicians – increase testing capacity 2 -4 fold = increased revenue Patients – more reliable results and better testing experience Health Systems – improved access for glaucoma testing

CURRENT MARKET Total Units (Zeiss, Haag-Streit) 80000 Annual turnover 10% or 8, 000 units

CURRENT MARKET Total Units (Zeiss, Haag-Streit) 80000 Annual turnover 10% or 8, 000 units Avg cost of new machine $35, 000 Annual opportunity $245 M

Diagnosed; Well-Monitored MARKET EXPANSION Diagnosed; Poorly Monitored Undiagnosed Diagnosed; Well-Monitored Diagnosed; Poorly Monitored Undiagnosed

Diagnosed; Well-Monitored MARKET EXPANSION Diagnosed; Poorly Monitored Undiagnosed Diagnosed; Well-Monitored Diagnosed; Poorly Monitored Undiagnosed

How? • Improved testing efficiencies • Expanding scope of practice of optometry • Novel

How? • Improved testing efficiencies • Expanding scope of practice of optometry • Novel opportunities for testing sites • Use of cloud-based software system • Integration of improved AI algorithms

EXPANDED MARKET OPPORTUNITY 4 X = ~ $1 B ANNUALLY

EXPANDED MARKET OPPORTUNITY 4 X = ~ $1 B ANNUALLY

COMPETITION 1. 2. Zeiss Meditech (80%) current focus not on ophthalmology VF Haag-Streit (20%)

COMPETITION 1. 2. Zeiss Meditech (80%) current focus not on ophthalmology VF Haag-Streit (20%) no evidence of HMD ambitions - Both have pursued cloud/AI data analysis, but are utilizing limited data from older machines 3. 4. IMO device (Japan) n. Goggles (Duke)

NOT OUR COMPETITION Companies focused on utilizing VR/AR for consumer vision applications • •

NOT OUR COMPETITION Companies focused on utilizing VR/AR for consumer vision applications • • • Vividly Vision Virtual Field Betasight Toronto Portable Perimeter Google Cardboard Visual Field Testing These are all inferior to the gold standard and will continue to be due to hardware limitations.

BIG PICTURE STRATEGY • Deliver LOWER capital cost solution with improved capacity • Enable

BIG PICTURE STRATEGY • Deliver LOWER capital cost solution with improved capacity • Enable ACCESS by additional purchasers (optometry) • EXPAND existing testing capacity with ophthalmologists • Develop CLINICAL gold standard with leading KOLs with continued improvements leveraging a cloud-based infrastructure and AI

DEVELOPMENT: PAST, PRESENT, & FUTURE TECHNICAL FINANCIAL • Proof of Concept • Prototype HMD

DEVELOPMENT: PAST, PRESENT, & FUTURE TECHNICAL FINANCIAL • Proof of Concept • Prototype HMD • MVP HMD Design • MVP HMD – Sept 2020 • Cube Design & Build • UI Software (80%) • Testing Algorithms (80%) • Founder Investment (initial) • Ophthalmologists (pre-seed) • Awards • Government • $1. 2 M raised to date • Funds required to complete MVP • MVP Sept 2020

The TEAM Dr. Brennan Eadie Frank Eadie Ben Matthews Jake Mc. Geough Chris Meisner

The TEAM Dr. Brennan Eadie Frank Eadie Ben Matthews Jake Mc. Geough Chris Meisner Nisarg Patel Jayme Vianna Ophthalmologist, Glaucoma Corporate Lawyer Strategy & Business Development Project Manager Software Developer Research Engineer Glaucoma Researcher

SCIENTIFIC ADVISORS Dr. Balwantray Chauhan – Glaucoma Researcher Dr. Marcelo Nicolela – Glaucoma Specialist,

SCIENTIFIC ADVISORS Dr. Balwantray Chauhan – Glaucoma Researcher Dr. Marcelo Nicolela – Glaucoma Specialist, Ophthalmology Head Dr. Paul Rafuse – Glaucoma Specialist Dr. Lesya Shuba – Glaucoma Specialist

TECHNOLOGY PARTNERS Electrical & Mechanical Engineering Optical Design & Engineering Software Design LED/LCD Microdisplays

TECHNOLOGY PARTNERS Electrical & Mechanical Engineering Optical Design & Engineering Software Design LED/LCD Microdisplays

THE ASK We are seeking $500 K CDN in equity to get us to

THE ASK We are seeking $500 K CDN in equity to get us to MVP Will be planning for subsequent larger Series A round as well

Thank you for your time and attention! www. eadietech. com brennan@eadietech. com 902 -292

Thank you for your time and attention! www. eadietech. com brennan@eadietech. com 902 -292 -0873